During the past decade, SRH Wald-Klinikum Gera; Klinik für Hautkrankheiten und Allergologie conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 6 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "SRH Wald-Klinikum Gera; Klinik für Hautkrankheiten und Allergologie" are "Basal Cell Carcinoma" (2 trials), "Malignant Melanoma" (2 trials), "Advanced BRAFV600 Wild-type Melanoma" (1 trials), "Carcinoma, Non-Squamous Non-Small Cell Lung" (1 trials) and "Non-Squamous Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "SRH Wald-Klinikum Gera; Klinik für Hautkrankheiten und Allergologie" in a lesser frequency.

Most popular intervention types in "SRH Wald-Klinikum Gera; Klinik für Hautkrankheiten und Allergologie" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Cobimetinib" (2 trials), "Pemetrexed" (2 trials), "Placebo" (2 trials), "Vemurafenib" (2 trials) and "Atezolizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "SRH Wald-Klinikum Gera; Klinik für Hautkrankheiten und Allergologie" are 7 trials for "All" genders.

Currently, there are NaN active trials in "SRH Wald-Klinikum Gera; Klinik für Hautkrankheiten und Allergologie". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in SRH Wald-Klinikum Gera; Klinik für Hautkrankheiten und Allergologie, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in SRH Wald-Klinikum Gera; Klinik für Hautkrankheiten und Allergologie, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".